Edition:
United Kingdom

BeyondSpring Inc (BYSI.OQ)

BYSI.OQ on NASDAQ Stock Exchange Capital Market

18.90USD
15 Feb 2019
Change (% chg)

$0.99 (+5.53%)
Prev Close
$17.91
Open
$18.90
Day's High
$18.90
Day's Low
$18.90
Volume
50
Avg. Vol
2,089
52-wk High
$33.30
52-wk Low
$16.83

Chart for

About

BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $892.10
Shares Outstanding(Mil.): 22.84
Dividend: --
Yield (%): --

Financials

  BYSI.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -3.97 -- --
ROI: -268.89 8.92 14.45
ROE: -260.45 10.08 15.96

Earnings vs. Estimates